{
  "retracted": false,
  "timestamp": 1547078400000,
  "updates": [
    {
      "timestamp": 1578616825039,
      "identifier": {
        "doi": "10.1007/s10549-018-05105-8"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10549-017-4358-6"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial"
}
